Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Sofinnova Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
Sofinnova Partners

Sofinnova Partners

Operating

Sofinnova Partners: A Paris-based financial services firm specializing in global startup investments.

Location
Paris, Paris, FR
Founded
1972
Firm
Compare
Portfolio
Fundraising
Employees
News
Website

Sofinnova Partners is a Paris-based investment firm specializing in early-stage and startup investments across various sectors, with a strong focus on healthcare and biotechnology. The firm typically invests in Seed to Series C rounds, with occasional participation in later stages. Sofinnova Partners has a global reach, supporting innovative companies worldwide.

Notable portfolio companies include HotSpot Therapeutics, RefleXion Medical, and Chroma Medicine. The firm's investment philosophy emphasizes backing transformative technologies and supporting entrepreneurs throughout their growth journey. Sofinnova Partners offers value-add services to portfolio companies, leveraging its extensive network and industry expertise to accelerate their development and market penetration.

Sofinnova Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments47
Current Portfolio Count22
Total Portfolio Exits4

Top Investment Stages

Series A16 (34.8%)
Series B13 (28.3%)
Series C7 (15.2%)
Seed6 (13.0%)
Series D4 (8.7%)

Stage Mix

Series A 35%Series B 28%Series C 15%Seed 13%Series D 9%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Freya Biosciences logo

Freya Biosciences

Betteromics logo

Betteromics

l'école AI logo

l'école AI

Werewool logo

Werewool

Mediar Therapeutics logo

Mediar Therapeutics

Chroma Medicine logo

Chroma Medicine

Inspirna logo

Inspirna

Prometheus Materials logo

Prometheus Materials

DMC Biotechnologies logo

DMC Biotechnologies

HotSpot Therapeutics logo

HotSpot Therapeutics

Nitrase Therapeutics logo

Nitrase Therapeutics

Mozart Therapeutics logo

Mozart Therapeutics

Catamaran Bio logo

Catamaran Bio

CorVent Medical logo

CorVent Medical

RefleXion Medical logo

RefleXion Medical

Twentyeight-Seven Therapeutics logo

Twentyeight-Seven Therapeutics

InCarda Therapeutics logo

InCarda Therapeutics

Hookipa Pharma logo

Hookipa Pharma

Entourage Medical Technologies logo

Entourage Medical Technologies

Assia logo

Assia

Inside Secure logo

Inside Secure

Cresta Technology logo

Cresta Technology

Sequoia Pharmaceuticals logo

Sequoia Pharmaceuticals

Intransa logo

Intransa

BioSpace logo

BioSpace

Sofinnova Partners - Similar Investment Firms

Sofinnova Investments logo

Sofinnova Investments

sofinnova.com

Sofina logo

Sofina

sofinagroup.com

Innoven Partners logo

Innoven Partners

Sofia Fund logo

Sofia Fund

sofiafund.com

Innovacom logo

Innovacom

innovacom.com

Seventure Partners logo

Seventure Partners

seventure.fr

Inovia Capital logo

Inovia Capital

inovia.vc

Partech logo

Partech

Inventus Capital Partners logo

Inventus Capital Partners

inventuscap.com

Seed4Soft logo

Seed4Soft

seed4soft.com

Inference Partners logo

Inference Partners

Novit Ventures logo

Novit Ventures

novitventures.com

Sovereign Capital logo

Sovereign Capital

Start Capital logo

Start Capital

start-capital.com

Endpoint Ventures logo

Endpoint Ventures

endpoint.vc

Sofinnova Partners - Classification

Also Known As
  • Sofinnova Partners SAS
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
ISIC
  • 6630Fund management activities
Show 14 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6300Insurance Carriers
  • 6370Pension, Health, And Welfare Funds
  • 6371Pension, Health, And Welfare Funds
  • 6730Trusts
  • 6733Trusts, Except Educational, Religious, And Charitable
  • 6000Depository Institutions
  • 6200Security And Commodity Brokers, Dealers, Exchanges, And Services
  • 6280Services Allied With The Exchange Of Securities Or Commodities
  • 6720Investment Offices
  • 6282Investment Advice
  • 6722Management Investment Offices, Open-end